通心络联合规范西医治疗对缺血性心肌病患者血清氧化应激、hsCRP及血管内皮功能的影响

  • 摘要: 目的 探讨通心络联合规范西医治疗对缺血性心肌病(ICM)患者血清氧化应激、高敏CRP(hsCRP)及血管内皮功能的影响。方法 选择2008年9月至2011年4月在本院心内科住院确诊的ICM患者83例,患者随机分为2组:对照组及通心络治疗组。随访期半年,所有研究对象在初始及随访结束时两次行血脂、抗超氧阴离子自由基(O2-)活力(抗O2-活力)、丙二醛水平、hsCRP、外周血循环内皮微颗粒(EMP)及内皮祖细胞(EPC)水平检测,并记录两组患者药物不良反应的发生率。结果 在研究结束时,与对照组比较,通心络治疗组血清丙二醛、hsCRP及外周血循环EMP水平明显降低,血清抗O2-活力及外周血循环EPC明显升高,两组比较差异有统计学意义(P<0.05)。两组药物不良反应情况比较差异无统计学意义(P>0.05)。 结论 通心络可能降低ICM患者血清氧化应激及炎症水平,并可能改善ICM患者血管内皮功能。

     

    Abstract: objective This study was designed to investigate the effect of association of Tongxinluo and standard modern medicine treatment on serum oxidative stress, high sensitive C reactive protein(hsCRP)and vascular endothelial function in patients with ischemic cardiomyopathy(ICM).Methods Eighty-three patients with ICM were recruited to this study from 2008.9 to 2011.4. Patients were randomly divided into two groups: control group (n=41) and Tongxinluo treatment group (n=42).All subjects were followed up for 6 months. The levels of serum lipids, scavenging activity for superoxide anion radicals(O2-),malondialdehyde, hsCRP, circulating Endothelial progenitor cells(EPC) and endothelial- derived microparticles (EMP) were examined in all subjects at enrollment and the end of study. The incidences of adverse reactions for medicines in two study groups were taken down. Results At the end of this study, the levels of serum malondialdehyde, hsCRP and circulating EMP were significantly decreased and serum scavenging activity for O2-, circulating EPC were significantly increased in Tongxinluo treatment group in comparison with control group, P<0.05. There were no significant differences between the two groups on the incidences of adverse reactions for medicines. Conclusions Tongxinlong might decrease the levels of serum oxidative stress, inflammation and improve the vascular endothelial function in patients with ICM.

     

/

返回文章
返回